Acuson disappoints again despite management change
This article was originally published in Clinica
Acuson, the darling of the US investment community four years ago, has reported its second quarter in a row which has failed to live up to analysts' estimates on earnings. The last large independently-owned ultrasound company in the US has been unable to turn round its lacklustre financial performance, despite replacing the company's president in March.
You may also be interested in...
The European Court of Justice has confirmed the European Medicines Agency’s approach to disclosure of data submitted as part of a marketing authorization application. It is a big disappointment for industry, which nonetheless says it supports responsible data sharing and will support efforts to develop a balanced approach.
Dr Reddy’s sees its Indian domestic market and China as hot prospects as it pursues its “transformation journey” in which it is reducing its dependence on the slowing US market.